Using Genomic Assays to Learn Which Patients With Breast Cancer Could Get Less Treatment

Coverage from the July 25, 2023, session of the Institute for Value-Based Medicine®, presented by The American Journal of Managed Care® in partnership with Emory's Winship Cancer Institute.

Related Keywords

United States ,San Antonio ,Texas ,American ,Kalinskyk Barlow ,Kevin Kalinsky ,Breast Cancer Research ,Glenn Family Breast Center ,Institute For Value ,National Cancer Institute ,Winship Cancer Institute ,Emory University Winship Cancer Institute ,American Society Of Clinical Oncology ,Emory University ,Winship Cancer ,Rand Glenn Family Chair ,Breast Medical Oncology ,Glenn Family Breast ,Value Based Medicine ,American Journal ,Managed Care ,San Antonio Breast Cancer Symposium ,American Society ,Clinical Oncology ,Antonio Breast Cancer Symposium ,Breast Cancer ,Hr Her2 ,Estrogen Driven ,Memory ,